4.8 Article

De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA

Journal

CANCER RESEARCH
Volume 69, Issue 2, Pages 431-439

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-08-1800

Keywords

-

Categories

Funding

  1. NIH/NINDS [1R21-NS055738-01A2]
  2. Randy Shaver Foundation
  3. Minnesota Medical Foundation
  4. NIH/NIDA [T32 DA022616]
  5. NIH/National Cancer Institute [R01CA113636-01A1]
  6. Minnesota Department of Employment and Economic Development [SPAP-05-0013-P-FY06]

Ask authors/readers for more resources

Spontaneous mouse models of cancer show promise to more accurately recapitulate human disease and predict clinical efficacy. Transgenic mice or viral vectors have been required to generate spontaneous models of glioma, a lethal brain tumor, because nonviral gene transfer is typically transient. To overcome this constraint, we used the Sleeping Beauty transposable element to achieve chromosomal integration of human oncogenes into endogenous brain cells of immunocompetent mice. Genetically engineered, spontaneous brain tumors were induced with plasmid DNA in a matter of weeks in three separate mouse strains. The phenotype of tumors was influenced by the combination of oncogenes delivered, resembling human astrocytoma or glioblastoma in the majority of cases. At least five different genes can be cotransfected simultaneously including reporters, allowing measurement of tumor viability by in vivo imaging. This model can accelerate brain tumor research in a variety of ways such as generation of humanized models for high throughput drug screening and candidate gene validation with exceptional speed and flexibility. [Cancer Res 2009;69(2):431.-9]

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available